Pentetate calcium trisodium (hameln pharma plus gmbh)
Welcome to the PulseAid listing for the Pentetate calcium trisodium drug offered from hameln pharma plus gmbh. This Lead Chelating Activity [MoA],Lead Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | hameln pharma plus gmbh |
NON-PROPRIETARY NAME: | pentetate calcium trisodium |
SUBSTANCE NAME: | PENTETATE CALCIUM TRISODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lead Chelating Activity [MoA],Lead Chelator [EPC] |
ROUTE: | INTRAVENOUS; RESPIRATORY (INHALATION) |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-08-11 |
END MARKETING DATE: | 0000-00-00 |
Pentetate calcium trisodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Pentetate calcium trisodium from hameln pharma plus gmbh |
LABELER NAME: | hameln pharma plus gmbh |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1000(mg/5mL) |
START MARKETING DATE: | 2004-08-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70651-001_ec78f8ef-25d3-40cd-82ed-32d49570708d |
PRODUCT NDC: | 70651-001 |
APPLICATION NUMBER: | NDA021749 |
Other PENTETATE CALCIUM TRISODIUM Pharmaceutical Manufacturers / Labelers: